Arcturus Therapeutics Holdings Inc. ARCT
10.55 USD +1.01 (+10.62%)
Nov 4, 2026, 1:15 PM EST
9.82 Day range 10.59
5.50 52-week range 17.96
- YTD
- +72.15%
- 1 year
- +18.17%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 79.47 +653.0% upside
Now 10.55
- Target (low)
- 44.00
- Target (mean)
- 79.47
- Target (high)
- 140.00
Ratings (0m) 10 10 buy · 0 hold · 0 sell
- Strong buy3
- Buy7
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 10
- 1 month ago 10
- 2 months ago 10
- 3 months ago 10
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.22333 | -0.40 – 0.59 | -0.32 | +169.8% | 45.92M | +35.1% | 8 |
| Next quarter | -0.2725 | -0.69 – 0.00 | -1.00 | +72.8% | 53.00M | +39.4% | 4 |
| Current year | -1.92 | -2.30 – -1.29 | 0.2765 | -794.4% | 175.51M | +3.3% | 8 |
| Next year | -1.48 | -5.15 – 3.12 | -1.92 | +22.8% | 213.90M | +21.9% | 8 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 17, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Dec 16, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Nov 8, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 12, 2024 | Leerink Partners | Initiated | — | Outperform |
| Aug 8, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 6, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Jul 2, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 10, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Mar 20, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 11, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Mar 8, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 8, 2024 | Wells Fargo | Maintained | Overweight | Overweight |
| Feb 8, 2024 | Citigroup | Maintained | Buy | Buy |
| Dec 13, 2023 | Canaccord Genuity | Initiated | — | Buy |
| Nov 28, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 15, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 27, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 20, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 5, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 22, 2023 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Aug 15, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 8, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 24, 2023 | William Blair | Initiated | — | Outperform |
| Jul 14, 2023 | Guggenheim | Maintained | Buy | Buy |
| Jul 14, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 14, 2023 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Jun 1, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| May 11, 2023 | HC Wainwright & Co. | Upgrade | Neutral | Buy |
| Mar 29, 2023 | Guggenheim | Reiterated | — | Buy |
| Mar 29, 2023 | HC Wainwright & Co. | Reiterated | — | Neutral |